Aspira Women's Health Inc.·4

Jun 10, 5:03 PM ET

FEINBERG LARRY N 4

4 · Aspira Women's Health Inc. · Filed Jun 10, 2020

Insider Transaction Report

Form 4
Period: 2020-06-08
Transactions
  • Exercise of In-Money

    Warrants to acquire Common Stock

    2020-06-08463,2980 total(indirect: See footnote)
    Exercise: $1.80From: 2017-08-17Exp: 2020-06-08Common Stock (463,298 underlying)
  • Exercise of In-Money

    Common Stock

    2020-06-08$1.80/sh+463,298$833,9366,137,052 total(indirect: See footnote)
Holdings
  • Common Stock

    (indirect: See footnote)
    1,555,555
  • Common Stock

    (indirect: See footnote)
    2,595,980
Footnotes (6)
  • [F1]These securities are owned by Oracle Partners, LP. ("Partners").
  • [F2]These securities are owned by Oracle Institutional Partners, L.P. ("Institutional Partners").
  • [F3]These securities are owned by Oracle Ten Fund, L.P. ("Ten Fund").
  • [F4]Larry N. Feinberg serves as the managing member of Oracle Associates, LLC, the general partner of Partners, Institutional Partners and Ten Fund, and accordingly, may be deemed to be the indirect beneficial owner of the shares beneficially owned by Partners, Institutional Partners and Ten Fund. Mr. Feinberg is the sole shareholder, director and president of Oracle Investment Management, Inc., which serves as investment manager to Partners, Institutional Partners and Ten Fund, and accordingly, may be deemed to be the beneficial owner of the shares beneficially owned by Partners, Institutional Partners and Ten Fund.
  • [F5]Each of the Reporting Persons identified in this statement disclaims beneficial ownership of the securities described in this statement, except to the extent of their individual respective pecuniary interest in such securities. The filing of this statement shall not be deemed an admission that any of the Reporting Persons identified in this statement are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owner of any securities specified in this statement other than those directly beneficially owned by them.
  • [F6]The original Warrant expiration date was 2/17/2022, which date was accelerated by the Issuer to 6/8/2020 upon notice to the Reporting Persons.

Documents

1 file
  • 4
    tm2022328d2_4.xmlPrimary

    OWNERSHIP DOCUMENT